Outcomes of rechargeable sacral neuromodulation for faecal incontinence: A single-centre observational study.

ABSTRACT:

Introduction

Faecal incontinence (FI) remains a debilitating condition with considerable psychosocial burden. Rechargeable sacral neuromodulation (rSNM) systems offer extended battery longevity and MRI compatibility, potentially reducing surgical burden. However, real-world data on their efficacy, safety and acceptability remain limited.

Method

This single-centre observational cohort study evaluated 37 patients who received rSNM (InterStim™ Micro) for FI between August 2020 and August 2022. Patients completed validated questionnaires (St Mark's FI Score, Rockwood FIQOL, SF-36) and a structured telephone interview assessing functional outcomes, adverse events and device satisfaction. Clinical records were reviewed for surgical and 3- to 5-year follow-up data.

Results

M

SUBMITTER: Okocha M 

PROVIDER: S-EPMC12719927 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature